Increased remineralization of tooth enamel by milk containing added casein phosphopeptide-amorphous calcium phosphate.
Casein phosphopeptide amorphous calcium phosphate nano-complexes (CPP-ACP) in chewing gum, lozenges and mouthrinses have been shown to re-mineralize enamel subsurface lesions in human in situ experiments. The aim of this double-blind, randomized clinical study was to investigate the capacity of CPP-ACP added to bovine milk to re-mineralize enamel subsurface lesions in situ. Ten subjects drank milk containing either 2.0 or 5.0 g CPP-ACP/l or a control milk whilst wearing removable appliances with enamel slabs containing subsurface demineralized lesions. Each 200 ml milk sample was consumed once a day for each weekday over three consecutive weeks. After each treatment and one weeks rest the subjects crossed over to the other treatments. At the completion of the treatments the enamel slabs were removed and remineralization determined using microradiography and microdensitometry. The results demonstrated that all three milk samples re-mineralized enamel subsurface lesions. However, the milk samples containing CPP-ACP produced significantly greater remineralization than the control milk. The re-mineralizing effect of CPP-ACP in milk was dose-dependent with 2.0 and 5.0 g CPP-ACP/l producing an increase in mineral content of 70 and 148%, respectively, relative to the control milk. The differences in remineralization following exposure to the three milk samples were all statistically significant (P<0.001). In conclusion, this study shows that the addition of 2.0-5.0 g CPP-ACP/l to milk substantially increases its ability to re-mineralize enamel subsurface lesions.
Walker
Glenn
G
Centre for Oral Health Science, School of Dental Science, The University of Melbourne, Australia.
Cai
Fan
F
Shen
Peiyan
P
Reynolds
Coralie
C
Ward
Brent
B
Fone
Christopher
C
Honda
Shuji
S
Koganei
Megumi
M
Oda
Munehiro
M
Reynolds
Eric
E
D000278:Administration, Buccal; D000818:Animals; D002327:Cariostatic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D002364:Caseins / Q000008:administration & dosage / Q000494:pharmacology*; D018592:Cross-Over Studies; D003720:Densitometry / Q000379:methods; D003743:Dental Enamel / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004338:Drug Combinations; D006801:Humans; D008852:Microradiography / Q000379:methods; D008892:Milk; D014089:Tooth Remineralization / Q000379:methods*
D002327:Cariostatic Agents; D002364:Caseins; D004338:Drug Combinations; C447032:casein phosphopeptide-amorphous calcium phosphate nanocomplex